↓ Skip to main content

What Next After Metformin? Thinking Beyond Glycaemia: Are SGLT2 Inhibitors the Answer?

Overview of attention for article published in Diabetes Therapy, August 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
23 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
70 Mendeley
Title
What Next After Metformin? Thinking Beyond Glycaemia: Are SGLT2 Inhibitors the Answer?
Published in
Diabetes Therapy, August 2019
DOI 10.1007/s13300-019-00678-z
Pubmed ID
Authors

Marc Evans, Angharad R. Morgan, Zaheer Yousef

X Demographics

X Demographics

The data shown below were collected from the profiles of 23 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 70 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 14%
Student > Master 7 10%
Researcher 4 6%
Student > Postgraduate 4 6%
Student > Ph. D. Student 4 6%
Other 11 16%
Unknown 30 43%
Readers by discipline Count As %
Medicine and Dentistry 20 29%
Pharmacology, Toxicology and Pharmaceutical Science 9 13%
Nursing and Health Professions 4 6%
Psychology 2 3%
Biochemistry, Genetics and Molecular Biology 1 1%
Other 1 1%
Unknown 33 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 October 2019.
All research outputs
#2,429,164
of 23,576,969 outputs
Outputs from Diabetes Therapy
#99
of 1,055 outputs
Outputs of similar age
#51,148
of 343,674 outputs
Outputs of similar age from Diabetes Therapy
#5
of 27 outputs
Altmetric has tracked 23,576,969 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,055 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 343,674 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.